BeStock  
Stocks › Biotechnology › REPL

Replimune REPL

US equityMarket cap rank #2747Biotechnology
$19.07 −$0.16 (-0.83%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $19.09 +0.10%
Open$18.84
Prev close$19.23
Day range$18.69 – $19.50
Volume1.96M
Market cap$1.81B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership107.7%-6.74 pts vs. prior quarter
Institutions holding229+1 vs. prior quarter
Insider trades (recent)27 buys / 23 sellsNet buying
Short interest25.96% of floatDays to cover 8.3 · as of 30 Oct 2026
Short-sale volume share23.5%5-day average of daily volume

Short-sale volume as % of daily volume

15%21%27%33%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$24.89M (10 inflow days, 10 outflow days).

Net flow by order size, last 20 sessions

−$22.9MSuper−$2.0MBig+$3.6MMid+$11.3MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 43.4% of shares outstanding.

Largest holders

  • Baker Bros. Advisors LP11.65%
  • BlackRock9.28%
  • RTW Investments, LP7.82%
  • Ridgeback Capital Management LLC7.71%
  • Montanova Capital, LLC6.97%
  • State Street Global Advisors4.40%
  • Boxer Capital Management, LLC4.20%
  • Emerald Advisers, LLC3.84%

By investor type

  • Mutual Fund48.14%
  • Hedge Fund46.08%
  • Public Company7.45%
  • VC/PE Fund3.12%
  • Private Company2.26%
  • Individual/Insider1.60%
  • Insurance Company0.39%
  • Government Pension Fund0.15%

Reported short interest has fallen from 26.53% to 25.96% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Emerald Advisers, LLC Mutual Fund 2026/Q3 +3,644,844 3.8%
Morgan Stanley Public Company 2026/Q3 +1,444,862 2.3%
Morgan Stanley Investment Management Inc. Mutual Fund 2026/Q3 +1,444,862 2.3%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +499,549 3.6%
Vanguard Portfolio Management, LLC Mutual Fund 2026/Q3 +171,895 0.9%
Renaissance Technologies Corp. Hedge Fund 2026/Q3 +167,000 0.2%
Erste Asset Management GmbH Mutual Fund 2026/Q3 +165,000 2.4%
Montanova Capital, LLC Hedge Fund 2026/Q3 +2,219,164 7.0%
Ridgeback Capital Management LLC Mutual Fund 2026/Q3 +7,310,656 7.7%
Boxer Capital Management, LLC Hedge Fund 2026/Q3 +2,808,000 4.2%
BlackRock Mutual Fund 2026/Q3 +2,719,296 9.5%
Logos Global Management, L.P. Hedge Fund 2026/Q3 +2,500,000 2.6%
AQR Capital Management Hedge Fund 2026/Q3 +2,295,024 2.7%
The Goldman Sachs Group, Inc. Public Company 2026/Q3 +2,221,121 4.6%
Jane Street Group, LLC Private Company 2026/Q3 +1,894,400 2.5%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
8 Nov 2026 Joseph Slattery Independent Director Open Market Disposition -5,200 $21.80 1,467
2 Nov 2026 Paolo Pucci Former Independent Director Intent to Sell (Form 144) -138,700 $20.43 –
1 Nov 2026 Kapil Dhingra Independent Director Derivative Exercise and Sale -21,500 $19.00 21,669
1 Nov 2026 Kapil Dhingra Independent Director Derivative Exercise and Retained +21,669 $1.75 21,669
29 Oct 2026 Veleka Peeples-Dyer Former Independent Director Intent to Sell (Form 144) -10,000 $16.72 –
27 Oct 2026 Veleka Peeples-Dyer Former Independent Director Intent to Sell (Form 144) -12,000 $12.90 –
19 Aug 2026 Philip Astley-Sparke Executive Chairperson Other Disposition -50,000 – 1,276,889
16 Aug 2026 Emily Hill Chief Financial Officer Open Market Disposition -9,256 $14.28 37,937
10 Aug 2026 Baker Bros. Advisors LP Open Market Derivative Acquisiti +2,736,340 $0.00 2,609,946
9 Aug 2026 Emily Hill Chief Financial Officer Open Market Disposition -11,448 $12.97 26,361
9 Aug 2026 Sushil Patel Chief Executive Officer Open Market Disposition -39,341 $12.97 80,243
9 Aug 2026 Andrew Schwendenman Chief Accounting Officer & Treasurer Open Market Disposition -7,632 $12.97 17,273
9 Aug 2026 Konstantinos Xynos Chief Medical Officer Open Market Disposition -11,447 $12.97 50,258
31 May 2026 Christopher Sarchi Former Chief Commercial Officer Automatic Disposition -12,000 $9.24 31,725
17 May 2026 Philip Astley-Sparke Executive Chairperson Open Market Disposition -17,657 $5.08 1,326,889
17 May 2026 Emily Hill Chief Financial Officer Open Market Disposition -7,812 $5.08 37,809
17 May 2026 Sushil Patel Chief Executive Officer Open Market Disposition -37,324 $5.08 119,584
17 May 2026 Christopher Sarchi Former Chief Commercial Officer Open Market Disposition -8,626 $5.08 43,724
17 May 2026 Andrew Schwendenman Chief Accounting Officer & Treasurer Open Market Disposition -7,894 $5.08 24,905
17 May 2026 Konstantinos Xynos Chief Medical Officer Open Market Disposition -14,023 $5.08 61,705

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 24,609,876 26.0% 8.3
15 Oct 2026 23,165,699 24.6% 12.7
30 Sep 2026 23,128,025 24.5% 10.8
15 Sep 2026 22,754,597 24.2% 11.1
31 Aug 2026 23,519,650 25.0% 8.9
14 Aug 2026 24,866,611 26.5% 4.0

Discussion

No comments yet — be the first to weigh in on REPL.

Sign in to join the discussion.

Scroll to Top